Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer. uri icon

Overview

publication date

  • November 1, 2004

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.ctrv.2004.08.001

PubMed ID

  • 15531397

Additional Document Info

volume

  • 30

issue

  • 7